Ellie Diagnostics

Ellie Diagnostics is a pioneering force in the Health Care industry, with a focus on revolutionizing animal health diagnostics. Established in 2018 in the United States, the company's ethos is encapsulated in their slogan - "Rethink Diagnostics." Offering the premier independent full-service veterinary diagnostics laboratory, Ellie Diagnostics is committed to enhancing animal wellness by ensuring the accessibility of comprehensive wellness testing. The startup differentiates itself with its dedication to providing next-day lab results, complimentary shipping, pathology consultations, data protection, mobile access to orders and results, and innovative laboratory reporting. Their extensive test menu encompasses routine lab testing, histopathology, cytology, microbiology, and an array of specialty tests. The company's overarching objective is to cater to the specific needs of veterinary clinics, offering customized services tailored to individual requirements. In the latest funding round, conducted on 10 November 2021, Ellie Diagnostics secured a Private Equity investment from Avego Bioscience Capital. This injection of capital signifies a pivotal moment for the company as it underlines the confidence of a prominent player in the biotech investment landscape, signifying a strong vote of confidence in Ellie Diagnostics' vision and potential.